Zealand Pharma Zeydovio gets positive EU panel opinion
Zealand Pharma said the EMA’s Committee for Medicinal Products for Human Use issued a positive opinion recommending approval of its short bowel syndrome drug candidate Zeydovio (OMXCOP: ZEAL).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.